Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

The new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is v...

Descripción completa

Detalles Bibliográficos
Autores: Vivas, D, Roldan, V, Esteve-Pastor, MA, Roldan, I, Tello-Montoliu, A, Ruiz-Nodar, JM, Cosin-Sales, J, Gamez, JM, Consuegra, L, Ferreiro, JL, Marin, F, Arrarte, V, Anguita, M, Cequier, A, Perez-Villacastin, J
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
Repositorio:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
OAI Identifier:oai:isabial.fundanetsuite.com:p6592
Acceso en línea:https://isabial.portalinvestigacion.com/publicaciones6592
Access Level:acceso abierto
Palabra clave:COVID-19
Coronavirus
SARS-CoV-2
Thrombosis
Antithrombotics
id ES_ddfc7aa794c6477348707edff79bf26d
oai_identifier_str oai:isabial.fundanetsuite.com:p6592
network_acronym_str ES
network_name_str España
repository_id_str
spelling Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of CardiologyVivas, DRoldan, VEsteve-Pastor, MARoldan, ITello-Montoliu, ARuiz-Nodar, JMCosin-Sales, JGamez, JMConsuegra, LFerreiro, JLMarin, FArrarte, VAnguita, MCequier, APerez-Villacastin, JCOVID-19CoronavirusSARS-CoV-2ThrombosisAntithromboticsThe new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is very scarce information on the management of thrombotic risk, coagulation disorders, and anticoagulant therapy. In addition, the situation has also greatly influenced usual care in patients not infected with COVID-19. This article by the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology aims to summarize the available information and to provide a practical approach to the management of antithrombotic therapy. (C) 2020 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.EDICIONES DOYMA S A2020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://isabial.portalinvestigacion.com/publicaciones6592REVISTA ESPANOLA DE CARDIOLOGIAISSN: 03008932ISSNe: 15792242reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicanteinstname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)Españolinfo:eu-repo/semantics/openAccessoai:isabial.fundanetsuite.com:p65922026-06-12T10:20:37Z
dc.title.none.fl_str_mv Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
title Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
spellingShingle Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
Vivas, D
COVID-19
Coronavirus
SARS-CoV-2
Thrombosis
Antithrombotics
title_short Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
title_full Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
title_fullStr Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
title_full_unstemmed Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
title_sort Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
dc.creator.none.fl_str_mv Vivas, D
Roldan, V
Esteve-Pastor, MA
Roldan, I
Tello-Montoliu, A
Ruiz-Nodar, JM
Cosin-Sales, J
Gamez, JM
Consuegra, L
Ferreiro, JL
Marin, F
Arrarte, V
Anguita, M
Cequier, A
Perez-Villacastin, J
author Vivas, D
author_facet Vivas, D
Roldan, V
Esteve-Pastor, MA
Roldan, I
Tello-Montoliu, A
Ruiz-Nodar, JM
Cosin-Sales, J
Gamez, JM
Consuegra, L
Ferreiro, JL
Marin, F
Arrarte, V
Anguita, M
Cequier, A
Perez-Villacastin, J
author_role author
author2 Roldan, V
Esteve-Pastor, MA
Roldan, I
Tello-Montoliu, A
Ruiz-Nodar, JM
Cosin-Sales, J
Gamez, JM
Consuegra, L
Ferreiro, JL
Marin, F
Arrarte, V
Anguita, M
Cequier, A
Perez-Villacastin, J
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv COVID-19
Coronavirus
SARS-CoV-2
Thrombosis
Antithrombotics
topic COVID-19
Coronavirus
SARS-CoV-2
Thrombosis
Antithrombotics
description The new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is very scarce information on the management of thrombotic risk, coagulation disorders, and anticoagulant therapy. In addition, the situation has also greatly influenced usual care in patients not infected with COVID-19. This article by the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology aims to summarize the available information and to provide a practical approach to the management of antithrombotic therapy. (C) 2020 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
publishDate 2020
dc.date.none.fl_str_mv 2020
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://isabial.portalinvestigacion.com/publicaciones6592
url https://isabial.portalinvestigacion.com/publicaciones6592
dc.language.none.fl_str_mv Español
language_invalid_str_mv Español
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv EDICIONES DOYMA S A
publisher.none.fl_str_mv EDICIONES DOYMA S A
dc.source.none.fl_str_mv REVISTA ESPANOLA DE CARDIOLOGIA
ISSN: 03008932
ISSNe: 15792242
reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
instname_str Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
reponame_str r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
collection r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421933211156480
score 15,812429

Similares en LA Referencia